October 2019 Br J Cardiol 2019;26:145–8 doi:10.5837/bjc.2019.035
Protik Chaudhury, Min Aung, Rossella Barbagallo, Edward Barden, Swamy Gedela, Stuart J Harris, Henry O Savage, Jason N Dungu
Introduction Cardiac magnetic resonance (CMR) imaging has developed into a crucial diagnostic tool in all patients with known or suspected heart disease. The role of CMR in differentiating ischaemic from non-ischaemic heart disease is well established and there are extensive data in the literature correlating myocardial fibrosis, as identified by the late gadolinium hyperenhancement technique, with adverse outcomes in patients with cardiomyopathy.1 A regional CMR service for the Essex region in southeast England was established in 2012, serving a population of 1,393,587 (2011 census data) with the benefit of avoiding transfer of patients to L
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits